Commercio SURF

Surface Oncology Inc

-

00:00:00

Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement with GlaxoSmithKline Intellectual Property (No. 4) Limited to develop, manufacture, and commercialize antibodies that targets SRF813; and license agreement with Vaccinex, Inc. to develop, manufacture, and commercialize antibodies, which targets SRF114. The company was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.
Leggi tutto...

SURF
Specifiche commerciali

Cifre

3

Punto

0.001

Diffusione

floating

Dimensioni del contratto

1

Volume Min

1

Volume massimo

10,000

Volume Step

1

Scambio lungo (punti)

-0.310

Scambio breve (punti)

-0.180
Disponibile su
MT5, TV, cTrader
Ultimo aggiornamento a Novembre 1, 20:08 GMT+3
*Fonte dei dati: Prezzi del conto MT5 Server Prime

SURF
Calendario economico

Non sono stati trovati dati

Cambiamento 1D

-

PerchƩ BlackBull Mercati?

26k+

AttivitĆ  negoziabili

1:500

Leva fino a

Regolamentato

Multiregolamentato

24/7

Assistenza clienti

$0

Nessun deposito minimo

Calcolatore del margine

Calculation Results

Current Price

0.00

Required Margin

Converted Currency

Required Margin

Account Base Currency

Calcolatore di profitti e perdite

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Calcolatore di swap

Calculation Results

0.00

OpportunitĆ  di trading

Non sono stati trovati dati
Join Now